Safety of biological therapies in elderly inflammatory bowel diseases: a systematic review and meta-analysis

HIGHLIGHTS

  • who: Gustavo Drügg Hahn et al. from the Division of Gastroenterology, McGill University Health Centre, Montreal, QC H G , Canada have published the research work: Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis, in the Journal: (JOURNAL) of 29/07/2022
  • what: The aim of this study was to perform a systematic review and meta-analysis to assess the safety of available biologicals in the IBD population. Interestingly, this study showed no difference in AEs and infection rates among elderly IBD patients treated with anti-TNF, VDZ . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?